Carlsmed Inc (CARL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Sales | 50,511 | 27,165 |
| Cost of Goods | 12,471 | 7,117 |
| Gross Profit | 38,040 | 20,048 |
| Operating Expenses | 69,085 | 44,287 |
| Operating Income | -30,574 | -24,122 |
| Interest Expense | -1,268 | -9 |
| Other Income | -328 | -144 |
| Pre-tax Income | -29,634 | -24,257 |
| Net Income Continuous | -29,634 | -24,257 |
| Net Income | $-29,634 | $-24,257 |
| EPS Basic Total Ops | -2.12 | -6.11 |
| EPS Basic Continuous Ops | -2.08 | -5.97 |
| EPS Diluted Total Ops | -2.12 | -6.11 |
| EPS Diluted Continuous Ops | -2.08 | -5.97 |
| EPS Diluted Before Non-Recurring Items | -2.12 | -6.11 |
| EBITDA(a) | $-30,293 | $-23,977 |